AMicale des COXiens

Forum des actionnaires particuliers de NicOx
AccueilAccueil  GalerieGalerie  S'enregistrerS'enregistrer  ConnexionConnexion  

Partagez | 

 Les winners et les losers post réforme américaine

Aller en bas 


Nombre de messages : 515
Date d'inscription : 15/05/2008

MessageSujet: Les winners et les losers post réforme américaine   Ven 19 Mar - 18:19

(Reuters) -
Drugmakers, device companies and health insurers all got some good news
when Democrats in the U.S. House of Representatives released changes to
healthcare reform legislation on Thursday.

Hefty taxes on those three industries were
delayed by at least a year, among other adjustments to the bill that
seeks to overhaul the nation's healthcare system.Following are some of the winners and losers
for the healthcare industry based on the reconciliation bill the House
is considering along with the Senate's bill. A vote is expected on


The pharmaceutical industry largely keeps
its $80 billion agreement to provide savings and rebates. Its fees, to
be parceled out among companies such as Pfizer Inc and Merck & Co
Inc, would be delayed from 2010 to 2011, increasing from the initial
$2.3 billion a year to $2.7 billion.*
Overall, wider insurance coverage could help offset the costs by
providing more potential customers.*
Drugmakers warded off deeper price cuts in the Medicare program for the
elderly. The House had sought to fully close the so-called "doughnut
hole" where coverage drops temporarily after reaching a spending limit,
but the bill maintains the industry's 50 percent discount. The
government will pay for another 25 percent discount.* Lawmakers rejected Obama's plan to end
lucrative "pay-for-delay" settlements with brand-name drugmakers, a win
for both generic and brand name companies.*
The bill also discards an earlier provision that would have extended a
hospital drug discount program.


Fees for medical device
makers such as Boston Scientific and Medtronic Inc would be delayed
until 2013 after initial bills called for 2010. The sector earlier won a
reduction in an industry tax to $20 billion, down from $40 billion.* Rather than an overall industry fee, the
bill now contains a 2.9 percent sales tax. Certain products, such as
eyeglasses, contact lenses and others bought by consumers at stores are
Hospitals, which include companies such
as Universal Health Services Inc and Tenet Healthcare Corp, say they
kept their a $155 billion, 10-year deal accepting lower government
payments from Medicare and Medicaid in exchange for an expected boost in
insured customers.* A provision
that could have helped certain rural and children's hospitals through an
expanded hospital drug discount program was dropped.



While health insurers
overall still face tighter regulation, there was some good news.
Insurers such as Aetna Inc, Cigna Corp, UnitedHealth Group Inc and
WellPoint Inc saw their $67 billion, 10-year tax delayed until 2014.* Private Medicare plans called Medicare
Advantage would see their payments frozen in 2011, then lowered in 2012.
The plans, which can offer more benefits than traditional Medicare
coverage, would also have to spend at least 85 cents out of every dollar
on medical costs -- leaving 15 cents toward overhead and salaries,
among other things.* Consumer
protection provisions still aim to change the way companies do business,
banning denial of coverage for preexisting medical conditions and
ending limits on how much coverage patients can get from their insurers
over their lifetime. Certain curbs would be expanded to all health
insurance plans six months after the bill passes, while others take
effect in 2014.* The bill changes
penalties for individuals who do not buy health insurance as mandated.
The fine is lowered from $495 to $325 in 2015 and from $750 to $695 in
2016, but the alternative method of fining people using a percentage of
income increased slightly to 2.5 percent by 2016.* There are some potential bright spots: The
bill does not include President Barack Obama's call for federal
oversight of health insurance rates and premiums. It also expands tax
credits and other financing to help more people afford insurance.* Lawmakers have said up to 30 million more
Americans could have insurance with the reform.

GENERIC DRUGMAKERS* Overall, companies that make generic
versions of brand-name drugs still see little direct help, although
increasing insurance access could help more people buy medicine.* Generic drugmakers had been concerned
that closing the Medicare "doughnut hole" would turn people away from
cheaper, generic medicines. The bill includes a 75 percent discount on
generic drugs, the same as brand-name.

BED MAKERS* The bill keeps a 10
percent tax on consumers who use indoor tanning salons, seeking to raise
$2.7 billion by 2019 while discouraging use that can cause skin cancer.(Reporting by Susan
Heavey; Editing by Tim
Revenir en haut Aller en bas
Voir le profil de l'utilisateur
Les winners et les losers post réforme américaine
Revenir en haut 
Page 1 sur 1

Permission de ce forum:Vous ne pouvez pas répondre aux sujets dans ce forum
AMicale des COXiens :: Forum public :: Echanges sur NicOx-
Sauter vers: